Covance Opens Lab for Companion Diagnostics
LabCorp announced that its Covance Drug Development business will open a companion diagnostics lab in Morrisville, North Carolina.
The facility also includes a genomics and molecular pathology lab to support clinical trials and diagnostic testing development, and a nuclear magnetic resonance (NMR) laboratory that houses an NMR spectrometer, approved by the FDA. The site also houses manufacturing facilities for diagnostics materials and testing components.
Read the full release here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
